Credit Suisse Ag Alector, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Alector, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 90,715 shares of ALEC stock, worth $233,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,715

Previous 85,298 6.35%

Holding current value

$233,137

Previous $680,000 19.71%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$5.69 - $8.08 $30,822 - $43,769	5,417 Added 6.35%	90,715 $546,000
Q4 2023 Feb 08, 2024	BUY	$3.77 - $8.39 $6,096 - $13,566	1,617 Added 1.93%	85,298 $680,000
Q3 2023 Nov 13, 2023	BUY	$5.2 - $8.77 $28,984 - $48,883	5,574 Added 7.14%	83,681 $542,000
Q2 2023 Aug 11, 2023	BUY	$5.86 - $7.93 $55,265 - $74,787	9,431 Added 13.73%	78,107 $469,000
Q1 2023 May 10, 2023	BUY	$5.85 - $9.84 $37,299 - $62,739	6,376 Added 10.23%	68,676 $425,000
Q4 2022 Feb 13, 2023	BUY	$6.88 - $9.55 $119,698 - $166,150	17,398 Added 38.75%	62,300 $575,000
Q3 2022 Nov 10, 2022	SELL	$8.19 - $13.2 $1,498 - $2,415	-183 Reduced 0.41%	44,902 $425,000
Q2 2022 Aug 12, 2022	BUY	$7.65 - $14.24 $29,873 - $55,607	3,905 Added 9.48%	45,085 $458,000
Q1 2022 May 16, 2022	BUY	$13.02 - $20.78 $38,161 - $60,906	2,931 Added 7.66%	41,180 $587,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $12,906 - $17,035	667 Added 1.77%	38,249 $790,000
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $72,137 - $131,580	3,332 Added 9.73%	37,582 $857,000
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $96,782 - $140,365	6,244 Added 22.3%	34,250 $713,000
Q1 2021 May 14, 2021	SELL	$14.84 - $22.23 $904,438 - $1.35 Million	-60,946 Reduced 68.52%	28,006 $563,000
Q4 2020 Feb 12, 2021	SELL	$9.4 - $16.7 $501,198 - $890,427	-53,319 Reduced 37.48%	88,952 $1.35 Million
Q3 2020 Nov 13, 2020	BUY	$10.54 - $24.96 $679,861 - $1.61 Million	64,503 Added 82.94%	142,271 $1.5 Million
Q2 2020 Aug 12, 2020	BUY	$21.87 - $33.11 $1.28 Million - $1.94 Million	58,652 Added 306.82%	77,768 $1.9 Million
Q1 2020 May 13, 2020	SELL	$16.25 - $35.28 $240,451 - $522,038	-14,797 Reduced 43.63%	19,116 $462,000
Q4 2019 Feb 12, 2020	BUY	$14.17 - $20.3 $89,256 - $127,869	6,299 Added 22.81%	33,913 $584,000
Q3 2019 Nov 12, 2019	BUY	$14.42 - $22.2 $398,193 - $613,030	27,614 New	27,614 $397,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $212M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account